🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To observe the efficacy and safety of hydrochloride anlotinib combined with...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05772377
Treatments Being Tested
This phase II randomized trial compares the efficacy and safety of Toripali...
Status
Recruiting
Location
Dongguan People's Hospital
Start Date
2026-03-12
Trial ID
NCT07362979
This trial is a multi-center phase III clinical trial. The purpose of this ...
Status
Recruiting
Location
First Affiliated Hospital, Sun Yat-Sen University
Start Date
2023-05
Trial ID
NCT05860868
Treatments Being Tested
Definitive chemoradiotherapy (CRT) is the standard treatment option for unr...
Status
Active Not Recruiting
Location
Mian Xi
Start Date
2022-09-15
Trial ID
NCT05520619
Treatments Being Tested
Currently, adjuvant therapy is not recommended for patients with esophageal...
Status
Recruiting
Location
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Start Date
2018-11-01
Trial ID
NCT03731442
Treatments Being Tested
The present study is a randomized, control, phase II study of locally advan...
Status
Completed
Location
Department of Radiation Oncology, Xijing Hospital, Fourth Military
Start Date
2012-05
Trial ID
NCT01596868
Treatments Being Tested
The purpose of this study is to compare the efficacy and toxicity of early ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-12-01
Trial ID
NCT05524389
Treatments Being Tested
This phase II trial studies the safety and effectiveness of an induction ch...
Status
Completed
Location
Washington University School of Medicine
Start Date
2012-08-09
Trial ID
NCT01566435
The combination of surufatinib with neoadjuvant chemo-immunotherapy and def...
Status
Recruiting
Location
Sun yat-sen University Cancer Center
Start Date
2025-07-20
Trial ID
NCT07086469
Treatments Being Tested
NPC is one of the most common malignant tumors in the head and neck region ...
Status
Not Yet Recruiting
Location
Chengdu University of Traditional Chinese Medicine Second Clinical School/Affiliated Chengdu Fifth People's Hospital
Start Date
2025-01-20
Trial ID
NCT06781112